Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division Sort descending
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Sort descending Business Functional Area Erscheinungsdatum
Senior Scientist I/II, Immunology– Immunogenicity and Mechanistic Immunology group Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Okt 18, 2024
Senior Scientist - Target Biology and Discovery Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Okt 18, 2024
Coordinator, Global Program Management and Portfolio Excellence INSURGENTES Mexiko Biomedical Research CTS Research & Development Okt 15, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 07, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 10, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Innovative Medicines Research & Development Sep 10, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Director of Global & Swiss Media & Editorial Basel (City) Schweiz Corporate CTS Communications & Public Affairs Okt 18, 2024
Government Affairs Manager Moscow (City) Russische Foed. Corporate Affairs Innovative Medicines Communications & Public Affairs Jul 29, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Sep 03, 2024
Manager, Post Production & Video Services Hyderabad (Office) Indien Corporate Affairs CTS Communications & Public Affairs Okt 04, 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Okt 08, 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs Okt 08, 2024
Office Manager – Public Affairs (f/m/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Deutschland Corporate Affairs Innovative Medicines Einrichtungen und Verwaltung Sep 02, 2024
Executive Director, Public Affairs LaCan Region East Hanover USA Corporate Affairs Corporate Communications & Public Affairs Mai 09, 2024
Vice President of European Public Affairs Vilvoorde Belgien Corporate Affairs Innovative Medicines Communications & Public Affairs Okt 10, 2024
Patient Engagement Lead İstanbul Kavacık Türkei Corporate Affairs CTS Communications & Public Affairs Sep 03, 2024
Director, Sustainability & ESG Strategy (Health Equity / Access focus) Basel (City) Schweiz Corporate Affairs Corporate BD&L & Strategic Planning Okt 15, 2024
Comms & Engagement Manager Amsterdam Niederlande Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Schweiz Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Associate Director, Corporate Event Marketing Cambridge (USA) USA Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Manager, Corporate Marketing Creative & Design East Hanover USA Corporate Affairs CTS Communications & Public Affairs Okt 17, 2024
Manager, Digital Storytelling Remote Position (USA) USA Corporate Affairs CTS Communications & Public Affairs Okt 18, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Okt 09, 2024
Research & Development Quality Specialist Barcelona Gran Vía Spanien Development Innovative Medicines Quality Okt 15, 2024
Postgraduate Program in TRD-Biologics Basel (City) Schweiz Development Innovative Medicines Others Okt 15, 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development Jul 29, 2024
Senior Global Program Clinical Head, Oncology East Hanover USA Development Innovative Medicines Research & Development Aug 02, 2024
Associate Director Biostatistics London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Aug 05, 2024
Senior Principal Data Scientist London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Data and Digital Aug 05, 2024
Senior Principal Pharmacometrics London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Aug 05, 2024
Associate Director Pharmacometrics London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 03, 2024
Group Head, Global Aggregate Reports & Risk Management Barcelona Gran Vía Spanien Development Innovative Medicines Research & Development Aug 29, 2024
Associate Director Data & Digitalization Project Management Schaftenau Österreich Development Innovative Medicines Research & Development Sep 03, 2024
Associate Clinical Research Medical Director - Oncology RLT Remote Position (USA) USA Development Innovative Medicines Research & Development Aug 29, 2024
Senior Clinical Development Medical Director - Renal East Hanover USA Development Innovative Medicines Research & Development Aug 30, 2024
Global Regulatory Publishing Associate London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs Systems & Strategy Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Technology Transformation Sep 02, 2024
Regulatory Affairs CMC Senior Manager Schaftenau Österreich Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Publishing Specialist London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Manager Regulatory Affairs Process Excellence London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Submission Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Affairs Manager Medical Devices (UK or Austria) London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Manager Regulatory Policy & Intelligence London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs Medical Device Manager (Schaftenau, Austria) Schaftenau Österreich Development Innovative Medicines Research & Development Sep 02, 2024
Global Labeling Manager Hyderabad (Office) Indien Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Submission Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 03, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.